Homepage > Nachrichten > Text

NMPA Notice On Deadline Of Paying Review Fee For Registration

2022-01-13

On Dec 1, 2021, NMPA published a notice on the deadline of paying review fee for registration.

After official acceptance of domestic Class III, imported Class II and Class III medical device registration, modification, renewal and Class III high-risk medical device clinical trial approval application, the applicant shall pay the review fee to NMPA within 15 working days. If the payment not made within 15 working days after NMPA acceptance, the application will be considered as the self withdrawal by applicant, and NMPA will terminate its registration procedure.

Once the acceptance of registration application, the registration project will be transferred to NMPA CMDE within 3 working days for them to start review.

BradyKnows usually suggests the legal agent of overseas manufacturers based in China to pay review fees as it will save the time for currency exchange. Please feel free to reach out to BradyKnows for more information on the responsibilities of legal agent.